Brazil's dengue count is down sharply from last year's record. 246 people still died.
More than 410,000 probable cases so far in 2026, against 1.45 million for all of 2025. One state, Minas Gerais, accounts for roughly a sixth of the national case total on its own.
Brazil has recorded more than 410,000 probable dengue cases and 246 deaths so far in 2026, as of 22 June — a steep decline from 2025's full-year total of roughly 1.45 million confirmed cases and 1,793 deaths, but still a substantial ongoing toll in a year already being described as comparatively mild [s1].
The scale of the year-over-year drop
The gap between this year's running total and last year's full-year figure is large enough that even accounting for 2026 having roughly half a year still to run when this data was recorded, the trajectory points toward a meaningfully lighter dengue season than 2025 [s1]. Brazil's dengue burden has swung sharply from year to year in recent history — a pattern common to mosquito-borne diseases, where case counts respond to rainfall, temperature, and prior-year immunity in the population, among other factors the available reporting here doesn't itself break down.
Why one state carries so much of the national picture
Minas Gerais, a single Brazilian state, reported 64,304 probable dengue cases with 36,517 confirmed and 32 confirmed deaths as of the same 22 June date [s1] — meaning that one state accounts for roughly 16% of the national probable case count. That kind of concentration is typical for dengue in Brazil, where transmission tends to cluster heavily in specific states and municipalities rather than spreading evenly across the country, though this single data point doesn't establish how the disease is distributed across Brazil's other states.
The other two viruses riding the same mosquito
The same Aedes mosquitoes that spread dengue also carry chikungunya and Zika, and Brazil's national figures for the same period show both circulating alongside dengue: 58,000 chikungunya cases with 47 deaths, and 1,648 Zika cases nationally [s1]. Minas Gerais specifically reported 13,894 probable chikungunya cases (3 confirmed deaths) and 35 probable Zika cases with no deaths [s1]. Chikungunya's death count — 47 nationally against a much smaller case count than dengue's — reflects that the two diseases carry different fatality profiles, not that chikungunya is spreading faster than dengue this year.
What this data can and can't tell you
This is probable and confirmed case data reported to Brazilian health authorities as of a single date in June — it's a snapshot partway through the year, not a final 2026 total, and dengue activity in Brazil is not evenly distributed across the calendar year. The available reporting doesn't specify whether the national figures are trending up or down week to week as of the reporting date, only where the cumulative count stood on 22 June relative to 2025's full-year figure.
What to watch next
Whether Brazil's full-year 2026 total ultimately confirms this as a genuinely lighter dengue year relative to 2025, and whether the same pattern — mild nationally, concentrated heavily in specific states like Minas Gerais — holds as more of the year's data comes in.
Sources
- Brazil: Dengue and chikungunya in Minas Gerais — Outbreak News Today , June 22, 2026
More on
Bangladesh's dengue epidemic left the cities, and the season moved with it
Two 2026 papers describe the same shift: rural incidence now exceeds urban in some years, the peak has slid to October and November, and one in six hospitalised patients progressed to severe disease.
US dengue hit a record 3,798 cases in 2024, and 97% arrived with travellers
A CDC surveillance summary puts 2024 at 359% above the 2010–2023 annual average. The 2.8% that were locally acquired are the part that changes what mosquito control has to plan for.
An oral dengue drug protected 6 of 10 volunteers. The virus mutated in all of them
In a controlled human infection trial, high-dose mosnodenvir suppressed DENV-3 far below placebo. Resistance-associated changes appeared in every sequenced recipient and none of the placebo group.
Releasing sterile male mosquitoes cut dengue risk by about 70% in a Singapore trial
A cluster-randomised trial across 15 population clusters found mosquito abundance collapsed in intervention areas and protective efficacy of 71–72% against symptomatic dengue.